February 8, 2025

		


| Tuesday, April 10th, 2012

Amgen to buy KAI for $315M

Latest news

Amgen said April 10 that it plans to buy San Francisco-based KAI Pharmaceuticals for $315 million in cash in a deal that would give it worldwide rights to an experimental treatment for patients with chronic kidney disease. Thousand Oaks-based Amgen said the deal would give it worldwide rights, excluding in Japan, to KAI’s lead product, Read More →

| Thursday, April 5th, 2012

Calavo to raise up to $200M

Agribusiness, Banking & Finance, Latest news, Tri-County Public Companies

Avocado marketer Calavo Growers said April 6 that it plans to raise up to $200 million in fresh capital by offering a mix of common stock and warrants for sale. The Santa Paula-based company said in regulatory filings that it would offer a combination of shares of common stock and warrants to raise the funds. Read More →

| Tuesday, April 3rd, 2012

Updated: SBCC Board placed on warning, four candidates named

Latest news

[Editor’s note: This article has been updated with information about SBCC’s search for a new president.] The same day Santa Barbara City College released a list of four finalists for its president position, the school announced that it has been placed on warning status. The warning comes almost a year after it received a complaint Read More →

| Tuesday, April 3rd, 2012

Teledyne increases stake in Optech

Banking & Finance, Latest news, Technology, Tri-County Public Companies

Military-industrial conglomerate Teledyne Technologies said April 3 that its Dalsa subsidiary has increased its ownership stake in the parent company of Optech from 19 percent to 51 percent. Terms of the deal were not disclosed. Optech is a Canadian maker of laser-based survey and digital imaging equipment. Thousand Oaks-based Teledyne has been moving away from Read More →

| Monday, April 2nd, 2012

Amgen, AstraZeneca strike drug development deal

Banking & Finance, Latest news, Technology, Tri-County Public Companies

Amgen has entered a development deal with London-based AstraZeneca to jointly commercialize five anti-inflammation drugs. Under the terms of the agreement announced April 2, AstraZeneca will pay a one-time $50 million payment to Amgen and will be responsible for helping the Thousand Oaks-based biotech giant commercialize its inflammation drug pipeline. The firms said in a Read More →

| Tuesday, March 27th, 2012

Ojai Community Bank out from regulatory order

Banking & Finance, Banking Industry, Latest news

Ojai Community Bank is out from under a regulatory consent order imposed on it last year and reported a profitable 2011, swinging back from a loss the year earlier. The small Ojai-based bank said March 27 that regulators had lifted a Federal Deposit Insurance Corp. order placed on it on March 31, 2011. The announcement Read More →

| Friday, March 23rd, 2012

Guest op/ed: The business world needs women to help us get out of this mess

Op/Eds, Opinion

Traditional male-centric business practices as well as unregulated policies imposed on our modern society got us into this global recession.